Literature DB >> 3871347

Presence of corticotropin-releasing factor-like immunoreactivity in human tumors.

I Wakabayashi, T Ihara, M Hattori, Y Tonegawa, T Shibasaki, K Hashimoto.   

Abstract

Corticotropin-releasing factor (CRF)-like immunoreactivity was measured by radioimmunoassay in human organs and tumors associated with and without ectopic adrenocorticotropic hormone (ACTH) syndrome. It was found to be distributed widely in the stomach, pancreas, adrenal gland, and various tumors (e.g., medullary thyroid carcinoma, small cell carcinoma of the lung, pheochromocytoma, and adenocarcinoma of the gastrointestinal tract and pancreas) in a concentration less than one tenth of that of the hypothalamus. Dilution curves of CRF-like immunoreactivity in tissue extracts paralleled that of synthetic rat (human) CRF. Sephadex G-50 gel filtration showed that a major CRF-like immunoreactivity in tissue extracts coeluted with synthetic rat (human) CRF. Results suggest that a material(s) closely related immunologically to CRF is present widely in normal and tumor tissues outside of the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871347     DOI: 10.1002/1097-0142(19850301)55:5<995::aid-cncr2820550513>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  ACTH-secreting pheochromocytoma with false-negative ACTH immunohistochemistry.

Authors:  Maria Francesca Cassarino; Alberto Giacinto Ambrogio; Luca Pagliardini; Martina De Martin; Valeria Barresi; Francesco Cavagnini; Francesca Pecori Giraldi
Journal:  Endocr Pathol       Date:  2012-09       Impact factor: 3.943

Review 2.  The corticotropin releasing factor system in cancer: expression and pathophysiological implications.

Authors:  Athina Kaprara; Kalliopi Pazaitou-Panayiotou; Alexandros Kortsaris; Ekaterini Chatzaki
Journal:  Cell Mol Life Sci       Date:  2010-02-09       Impact factor: 9.261

3.  Limited clinical usefulness of plasma corticotropin-releasing hormone, adrenocorticotropin and beta-endorphin measurements as markers of lung cancer.

Authors:  A E Calogero; G Minacapilli; A M Nicolosi; M L Moncada; A Mistretta; S F Latteri; P Polosa; R D'Agata
Journal:  J Endocrinol Invest       Date:  1992-09       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.